Acadia Healthcare Company, Inc.
Cash Flow Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $4.1M | $-1.18B | $36.2M | $30.1M | $8.4M | $32.6M | $68.1M | $78.5M |
| Depreciation & Amortization | $52.4M | $45.8M | $47.5M | $49.0M | $47.0M | $39.5M | $37.6M | $36.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $8.0M | $6.5M | $6.0M | $10.5M | $8.7M | $10.1M | $9.5M | $8.9M |
| Net Cash from Operating Activities | $61.5M | $-86.3M | $73.2M | $133.5M | $11.5M | $116.7M | $163.1M | $171.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $76.6M | $93.2M | $136.2M | $167.7M | $174.6M | $203.5M | $190.2M | $154.2M |
| Business Acquisitions | — | $0 | $0 | $-429.0K | $8.6M | $0 | $2.8M | $369.0K |
| Net Cash from Investing Activities | $-60.2M | $-92.4M | $-129.8M | $-150.8M | $-183.2M | $-203.3M | $-193.1M | $-155.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | $0 | $0 | $3.2M | $46.9M | — | — | — |
| Net Cash from Financing Activities | $23.9M | $193.3M | $43.8M | $57.5M | $186.7M | $80.8M | $34.9M | $-15.8M |
| Net Change in Cash | $25.2M | $14.5M | $-12.7M | $40.2M | $14.9M | $-5.8M | $5.0M | $-136.0K |
| Free Cash Flow | $-15.0M | $-179.5M | $-63.0M | $-34.2M | $-163.2M | $-86.8M | $-27.1M | $16.9M |